shadow shadow shadow shadow shadow
    Country
    Opportunity Status
    Funding Instrument Type
    Category
    Clear

    Enhancing Public Health Surveillance of Bleeding Disorders

    CDC-RFA-DD-25-0124

    Brandi Dupervil

    Opening date 2 Aug 2024, 12:00AM

    Closing date N/A

    Funding Opportunity Number: CDC-RFA-DD-25-0124

    Opportunity Category: Discretionary

    Expected Number of Awards: 1

    CFDA Number(s): 93.080 -- Blood Disorder Program: Prevention, Surveillance, and Research

    Cost Sharing or Matching Requirement: No

    Posted Date: Aug 02, 2024 12:00:00 AM EDT

    Closing Date: N/A

    Estimated Total Program Funding: 21500000

    Award Ceiling: $4300000

    Award Floor: $100000

    Eligible Applicants: For profit organizations other than small businesses,Small businesses,Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education,Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility",Public and State controlled institutions of higher education,County governments,Native American tribal governments (Federally recognized),City or township governments,Private institutions of higher education,State governments,Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education,Special district governments,Independent school districts,Others (see text field entitled "Additional Information on Eligibility" for clarification),Public housing authorities/Indian housing authorities,Native American tribal organizations (other than Federally recognized tribal governments)

    Additional Information on Eligibility: N/A

    Description: Hemophilia, von Willebrand disease and other inherited bleeding disorders cause significant disease burden and reduced quality of life. The purpose of this NOFO is to collect and utilize surveillance data within the network of federally supported hemophilia treatment centers to inform policies and clinical practices. The NOFO will build upon the current surveillance infrastructure to characterize bleeding disorders, increase understanding of treatment practices and patterns, monitor inhibitors and other health complications, and identify causes of death among persons with bleeding disorders. The long-term outcomes are to reduce and prevent health complications and improve the quality of life of those living with bleeding disorders.

    We use cookies and similar technologies that are necessary to operate the website.Please read our cookie policy.

    We use cookies and similar technologies that are necessary to operate the website. Additional cookies are only used with your consent. We use the additional cookies to perform analyses of website usage and to check marketing measures for their efficiency. These analyses are carried out to provide you with a better user experience on the website. You are free to give, deny, or withdraw your consent at any time by using the "cookie settings" link at the bottom of each page. You can consent to our use of cookies by clicking "Agree". For more information about what information is collected and how it is shared with our partners, please read our cookie policy.

    • Required to run the website
    • Monitoring website usage and optimizing the user experience
    • Evaluation of marketing actions
    • Storage of your preferences from previous visits
    • Collecting user feedback to improve our website
    • Recording of your interests in order to provide customised content and offers
    Cookie Settings Accept